scholarly article | Q13442814 |
P50 | author | Boris D. Zlatopolskiy | Q55241227 |
Heike Endepols | Q88619102 | ||
P2093 | author name string | Bernd Neumaier | |
Alexander Drzezga | |||
Markus Dietlein | |||
Philipp Krapf | |||
Raphael Richarz | |||
Elizaveta A Urusova | |||
Melanie Hohberg | |||
Mehrab Guliyev | |||
P2860 | cites work | Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma | Q40278887 |
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer | Q41319390 | ||
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer | Q41905456 | ||
Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake | Q45105171 | ||
Tetrabutylammonium tetra(tert-butyl alcohol)-coordinated fluoride as a facile fluoride source | Q46339661 | ||
High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner | Q46802169 | ||
Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer. | Q47156816 | ||
Discovery of 7-[18F]Fluorotryptophan as a Novel Positron Emission Tomography (PET) Probe for the Visualization of Tryptophan Metabolism in Vivo | Q48154779 | ||
Neither azeotropic drying, nor base nor other additives: a minimalist approach to (18)F-labeling | Q85252798 | ||
Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin Inhibitors | Q27684776 | ||
Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer | Q28236013 | ||
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients | Q33841484 | ||
An improved synthesis of the radiolabeled prostate-specific membrane antigen inhibitor, [(18) F]DCFPyL. | Q33917903 | ||
Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. | Q34702948 | ||
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer | Q35938051 | ||
PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT? | Q36421964 | ||
Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates | Q36818334 | ||
Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer | Q37478039 | ||
How to design PET experiments to study neurochemistry: application to alcoholism | Q37615648 | ||
PSA-Stratified Performance of 18F- and 68Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer. | Q38788408 | ||
(18)F-DCFPyL PET/CT in the detection of prostate cancer at 60 and 120 minutes ; detection rate, image quality, activity kinetics and biodistribution | Q38815886 | ||
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer | Q39449818 | ||
Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models. | Q39797249 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 817-823 | |
P577 | publication date | 2018-11-02 | |
P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
P1476 | title | Discovery of 18F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions | |
P478 | volume | 60 |
Q92423926 | 18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging |
Q90140874 | 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer |
Q92190795 | Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer |
Q64911922 | Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents. |
Q89529826 | Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology |
Search more.